Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Aleksandra B Lasica und 30 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Harvard University, Boston, MA, USA. Hauptthemen laut MEDLINE: Astrocytoma, Isocitrate Dehydrogenase, Mutation, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Astrocytoma, isocitrate dehydrogenase-mutant, WHO grade 4 (Astro4), is a new tumor type in the 2021 WHO classification of central nervous system tumors that has been poorly characterized in the literature. This study evaluates predictors of prognosis in a large cohort of newly diagnosed Astro4.
Methods
We retrospectively identified 128 consecutive adult patients who presented with an initial diagnosis of Astro4 at Dana-Farber Cancer Institute and Massachusetts General Hospital between 2010 and 2021. Clinical, molecular, and radiological characteristics were recorded, and their associations with overall survival (OS) and progression-free survival (PFS) were measured by log-rank test and Cox proportional hazards model.
Results
The median age at diagnosis was 37.1 years, and 61.7% were men. The median OS was 5.9 years (95% confidence interval, 4.4–7.3), while the median PFS was 2.7 years (1.8 –3.6). Age ≥ 50 and homozygous CDKN2A/B deletion were independent negative prognosticators of OS on univariate and multivariate analyses (hazard ratio [HR], 2.21 [1.16–4.21], P = .019; HR, 2.61 [1.27–5.38], P = .013). Maximal resection of enhancing disease was associated with longer PFS on univariate and multivariate analyses (HR, 0.48 [0.26–0.87], P = .019). There were no significant differences in OS or PFS based on MGMT promoter methylation status, T2/FLAIR extent of resection, T2/FLAIR mismatch, radiological pseudoprogression, or enhancement on the pre-operative scan.
Conclusions
Our study comprehensively characterizes a large cohort of newly diagnosed patients with Astro4, emphasizing the prognostic value of CDKN2A/B deletion, age, and the extent of resection of enhancing disease in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard Medical School, Harvard University, Boston, MA, USA.
- Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Center for Clinical Investigation, Brigham and Women's Hospital, Boston, MA, USA.
- Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
- Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
- Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
ORCID-Profile: Aleksandra B Lasica, Elisa Aquilanti, Ugonma Chukwueke, Lakshmi Nayak, Daniel P Cahill, Vihang Nakhate, Gilbert Youssef
Zitieren
APA
Lasica, A. B., Lan, Z., Miller, J. J., Jiao, A., Pan, I., Aker, L., Prabhakar, P., Japo, J., Russ, A., Westergaard, C., Aquilanti, E., Chukwueke, U., Gonzalez Castro, L. N., McFaline Figueroa, J. R., Lee, E. Q., Nayak, L., Beroukhim, R., Batchelor, T. T., Cahill, D. P., …, & Youssef, G. (2025). Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf133
Vancouver
Lasica AB, Lan Z, Miller JJ, Jiao A, Pan I, Aker L, et al. Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf133
BibTeX
@article{Lasica2025,
author = {Lasica, Aleksandra B and Lan, Zhou and Miller, Julie J and Jiao, Albert and Pan, Ian and Aker, Loai and Prabhakar, Prem and Japo, Julia and Russ, Alyssa and Westergaard, Catharina and Aquilanti, Elisa and Chukwueke, Ugonma and Gonzalez Castro, L Nicolas and McFaline Figueroa, J Ricardo and Lee, Eudocia Quant and Nayak, Lakshmi and Beroukhim, Rameen and Batchelor, Tracy T and Cahill, Daniel P and Nakhate, Vihang and Lanman, Tyler and Pablo Ospina, Juan and Stec, Natalie and Patel, Ruchit V and Meredith, David M and Bi, Wenya Linda and Reardon, David A and Ligon, Keith L and Huang, Raymond Y and Wen, Patrick Y and Youssef, Gilbert},
title = {Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf133}
}
EUVIMED